China Government Report On Drug Regulation Seeks To Increase Transparency
This article was originally published in PharmAsia News
Executive Summary
BEIJING - As part of a drive to open China's drug regulatory system to public scrutiny and foster international cooperation, the Chinese government has released a ground-breaking report on the current state of its industry oversight